Ibandronate Sodium
Who holds supplier records for Ibandronate Sodium? 12 organisations hold a current record for Ibandronate Sodium: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), Canada (1), Poland (1) and Argentina (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ibandronate Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ibandronate-sodium
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
8 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ibandronate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 20466, 22300 · latest filing Dec 2008
- Natco PharmaIndia Company GMP cert on recordActive DMF 24824, 20411 · latest filing May 2011
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 20393 · latest filing Mar 2007
- Apotex Inc.CanadaActive DMF 20525 · latest filing May 2007
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 25172 · latest filing Sept 2011
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 25793 · latest filing Apr 2012
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 20422 · latest filing Apr 2007
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 20605 · latest filing Jun 2007
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 25638 · latest filing Dec 2011
- IndiaCEP Company GMP cert on record
- ArgentinaCEP Company GMP cert on record
- PHARMACEUTICAL WORKS POLPHARMA SACEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Ibandronate Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| FLEMING LABORATORIES LIMITED Hyderabad | IN | CEP 2022-338 - Rev 01 Ibandronate sodium monohydrate | Jun 2026 | — |
| MAPRIMED S.A. Buenos Aires | AR | CEP 2025-243 - Rev 00 Ibandronate sodium monohydrate | Feb 2026 | Inspected Jul 2025 France |
| PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski | PL | R0-CEP 2023-077 - Rev 00 Ibandronate sodium monohydrate, Type I | Jun 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Ibandronate Sodium are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 20494 · filed Apr 2007
- Italy · Inactive DMF 20427 · filed Apr 2007
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ibandronate Sodium is a bisphosphonate class drug used to prevent and treat osteoporosis in postmenopausal women. It works by inhibiting osteoclast-mediated bone resorption, thus increasing bone mineral density.
Chemical identity
- IUPAC name
- sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;hydrate
- Canonical SMILES
- CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]
- InChIKey
- VBDRTGFACFYFCT-UHFFFAOYSA-M
- Synonyms
- Boniva API, bm-21.0955, bm-210955, boniva, dp-r206 component ibandronate, ibandronate sodium hydrate, ibandronate sodium monohydrate, ibandronic acid (as sodium ibandronate), ibandronic acid sodium salt, ibandronic acid sodium salt monohydrate, ibandronic sodium monohydrate, ibandronate monosodium monohydrate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Bisphosphonate
- Chemical structure
- Diphosphonates
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ibandronate Sodium?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Ibandronate Sodium: Dr. Reddy's Laboratories Ltd. (India), Natco Pharma (India), APITORIA PHARMA PRIVATE LTD (India), Apotex Inc. (Canada), Emcure Pharmaceuticals Limited (India), Macleods Pharmaceuticals Ltd. (India), ORBION PHARMACEUTICALS PRIVATE LTD (India) and Sun Pharmaceutical Industries Limited (India), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ibandronate Sodium Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 20466, 22300), Natco Pharma (DMF 24824, 20411), APITORIA PHARMA PRIVATE LTD (DMF 20393), Apotex Inc. (DMF 20525), Emcure Pharmaceuticals Limited (DMF 25172), Macleods Pharmaceuticals Ltd. (DMF 25793), ORBION PHARMACEUTICALS PRIVATE LTD (DMF 20422) and Sun Pharmaceutical Industries Limited (DMF 20605) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ibandronate Sodium records mean?
2 organisations have only inactive Type II DMFs for Ibandronate Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ibandronate Sodium have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Ibandronate Sodium on the EDQM register, including FLEMING LABORATORIES LIMITED Hyderabad (IN), MAPRIMED S.A. Buenos Aires (AR) and PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski (PL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ibandronate Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ibandronate Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.